XML 116 R96.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income tax expense/(benefit), Summary (Details) - AUD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income tax expense/(benefit) [Abstract]      
Current tax expense [1] $ 32,422 $ 14,357 $ 9,428
Deferred tax benefit (26,285) (16,481) (3,971)
Income tax (benefit)/expense $ 6,137 $ (2,124) $ 5,457
[1] The current tax expense is attributable to Telix Innovations SA and Telix Pharmaceuticals US Inc and is driven by the individual entity’s taxable profits.